|[Note from Editor of "Towards Better|
Health": this is our choice of image.
Monsanto would do well to look at its
own "cancer of corruption" and not
disparage agencies like the IARC.]
In relation to the previous post, read here how Monsanto lies about the safety of its product, glyphosate.
IARC's Report on Glyphosate
Glyphosate has a long history of safe use. In evaluations spanning four decades, the overwhelming conclusion of experts worldwide has been that glyphosate, when used according to label directions, does not present an unreasonable risk of adverse effects to humans, wildlife or the environment.
In March 2015, IARC convened a meeting to evaluate the potential carcinogenic risks to humans from several pesticides, including glyphosate, an active ingredient in many popular herbicides, including Roundup brand herbicides. After that meeting the IARC panel classified glyphosate in Category 2A, a category that also includes red meat.
Based on the overwhelming weight of evidence, Monsanto strongly disagrees with IARC’s classification of glyphosate.
Importantly, IARC overlooked decades of thorough and science-based analysis by regulatory agencies around the world and selectively interpreted data to arrive at its classification of glyphosate. No regulatory agency in the world considers glyphosate to be a carcinogen.
Regulatory agencies have reviewed all the key studies examined by IARC – and many more – and arrived at the overwhelming consensus that glyphosate poses no unreasonable risks to humans or the environment when used according to label instructions.
In fact, since IARC classified glyphosate, regulatory authorities in Europe, Canada, Japan and Australia have publicly reaffirmed that glyphosate does not cause cancer. Additionally, in May 2016, the Joint FAO/WHO Meeting on Pesticide Residues (JMPR) concluded that “glyphosate is unlikely to pose a carcinogenic risk to humans from exposure through the diet.”
Click here to read a recent investigation by Reuters that reveals significant shortcomings and conflicts of interest with IARC’s process. The investigation helps put IARC’s erroneous classification of glyphosate into perspective.
Furthermore, to better understand how IARC arrived at such an inconsistent conclusion, Monsanto retained Intertek Scientific & Regulatory Consultancy to convene an expert panel to review IARC’s assessment. The panel evaluated IARC’s process and also examined the larger dataset evaluated by regulatory agencies. They concluded “none of the results from a very large database, using different methodologies, provides evidence of, or a potential mechanism for, human carcinogenesis.” The full abstract is available here.
Below are some resources and information about glyphosate safety. If you have specific questions about glyphosate or any of our other products, please feel free to ask us at discover.monsanto.com.